• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体4介导的血小板活化在组织因子引发的炎症中的重要作用。

Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.

作者信息

Busso Nathalie, Chobaz-Péclat Veronique, Hamilton Justin, Spee Pieter, Wagtmann Nicolai, So Alexander

机构信息

Laboratoire de Rhumatologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

出版信息

Arthritis Res Ther. 2008;10(2):R42. doi: 10.1186/ar2400. Epub 2008 Apr 15.

DOI:10.1186/ar2400
PMID:18412955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2453761/
Abstract

INTRODUCTION

Tissue factor (TF) activation of the coagulation proteases enhances inflammation in animal models of arthritis and endotoxemia, but the mechanism of this effect is not yet fully understood - in particular, whether this is primarily due to fibrin formation or through activation of protease activated receptors (PARs).

METHODS

We induced extravascular inflammation by injection of recombinant soluble murine TF (sTF1-219) in the hind paw. The effects of thrombin inhibition, fibrinogen and platelet depletion were evaluated, as well as the effects of PAR deficiency using knockout mice deficient for each of the PARs.

RESULTS

Injection of soluble TF provoked a rapid onset of paw swelling. Inflammation was confirmed histologically and by increased serum IL-6 levels. Inflammation was significantly reduced by depletion of fibrinogen (P < 0.05) or platelets (P = 0.015), and by treatment with hirudin (P = 0.04) or an inhibitor of activated factor VII (P < 0.001) compared with controls. PAR-4-deficient mice exhibited significantly reduced paw swelling (P = 0.003). In contrast, a deficiency in either PAR-1, PAR-2 or PAR-3 did not affect the inflammatory response to soluble TF injection.

CONCLUSION

Our results show that soluble TF induces acute inflammation through a thrombin-dependent pathway and both fibrin deposition and platelet activation are essential steps in this process. The activation of PAR-4 on platelets is crucial and the other PARs do not play a major role in soluble TF-induced inflammation.

摘要

引言

凝血蛋白酶的组织因子(TF)激活可增强关节炎和内毒素血症动物模型中的炎症反应,但其作用机制尚未完全明确,特别是这主要是由于纤维蛋白形成还是通过蛋白酶激活受体(PARs)的激活。

方法

我们通过在后爪注射重组可溶性小鼠TF(sTF1-219)诱导血管外炎症。评估了凝血酶抑制、纤维蛋白原和血小板消耗的影响,以及使用每种PAR基因敲除小鼠的PAR缺乏的影响。

结果

注射可溶性TF引发爪部肿胀迅速出现。通过组织学检查和血清IL-6水平升高证实了炎症。与对照组相比,纤维蛋白原消耗(P<0.05)或血小板消耗(P = 0.015)以及用水蛭素治疗(P = 0.04)或活化因子VII抑制剂治疗(P<0.001)可使炎症显著减轻。PAR-4缺陷小鼠的爪部肿胀明显减轻(P = 0.003)。相比之下,PAR-1、PAR-2或PAR-3的缺陷均不影响对可溶性TF注射的炎症反应。

结论

我们的结果表明,可溶性TF通过凝血酶依赖性途径诱导急性炎症,纤维蛋白沉积和血小板激活都是这一过程中的关键步骤。血小板上PAR-4的激活至关重要,而其他PARs在可溶性TF诱导的炎症中不起主要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/ffe5d0bfc9a0/ar2400-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/56825427e637/ar2400-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/58ca9726269c/ar2400-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/0ee23cf4c51d/ar2400-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/6654fba608aa/ar2400-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/a4f792e77ed9/ar2400-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/ffe5d0bfc9a0/ar2400-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/56825427e637/ar2400-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/58ca9726269c/ar2400-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/0ee23cf4c51d/ar2400-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/6654fba608aa/ar2400-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/a4f792e77ed9/ar2400-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/2453761/ffe5d0bfc9a0/ar2400-6.jpg

相似文献

1
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.蛋白酶激活受体4介导的血小板活化在组织因子引发的炎症中的重要作用。
Arthritis Res Ther. 2008;10(2):R42. doi: 10.1186/ar2400. Epub 2008 Apr 15.
2
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.组织因子和蛋白酶激活受体在内毒素血症小鼠模型中的作用
Blood. 2004 Feb 15;103(4):1342-7. doi: 10.1182/blood-2003-09-3051. Epub 2003 Oct 23.
3
Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.内毒素血症和脓毒症中的组织因子、凝血蛋白酶及蛋白酶激活受体
Crit Care Med. 2004 May;32(5 Suppl):S293-7. doi: 10.1097/01.ccm.0000128445.95144.b8.
4
Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.纤维蛋白原和蛋白酶激活受体在急性外源性物质诱导的胆汁淤积性肝损伤中的作用。
Toxicol Sci. 2011 Jan;119(1):233-43. doi: 10.1093/toxsci/kfq327. Epub 2010 Oct 25.
5
Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.组织因子-因子VIIa复合物触发蛋白酶激活受体2依赖性生长因子释放并促进卵巢癌迁移。
Gynecol Oncol. 2017 Apr;145(1):167-175. doi: 10.1016/j.ygyno.2017.01.022. Epub 2017 Jan 29.
6
Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.组织因子在血栓形成中的作用。凝血-炎症-血栓形成环路。
Front Biosci. 2006 Jan 1;11:256-71. doi: 10.2741/1796.
7
Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.凝血依赖性炎症。凝血依赖性炎症与炎症依赖性血栓形成。
Front Biosci. 2006 Jan 1;11:59-80. doi: 10.2741/1780.
8
Endothelial cell-specific anticoagulation reduces inflammation in a mouse model of acute lung injury.内皮细胞特异性抗凝可减轻急性肺损伤小鼠模型中的炎症反应。
Acta Pharmacol Sin. 2019 Jun;40(6):769-780. doi: 10.1038/s41401-018-0175-7. Epub 2018 Nov 16.
9
The many faces of tissue factor.组织因子的多面性
J Thromb Haemost. 2009 Jul;7 Suppl 1(Suppl 1):136-9. doi: 10.1111/j.1538-7836.2009.03368.x.
10
Tissue factor mediates inflammation.组织因子介导炎症反应。
Arch Biochem Biophys. 2005 Aug 15;440(2):123-32. doi: 10.1016/j.abb.2005.06.005.

引用本文的文献

1
Role of protease-activated receptor 4 in mouse models of acute and chronic kidney injury.蛋白酶激活受体 4 在急性和慢性肾损伤小鼠模型中的作用。
Am J Physiol Renal Physiol. 2024 Feb 1;326(2):F219-F226. doi: 10.1152/ajprenal.00162.2023. Epub 2023 Nov 30.
2
Preliminary Study on Gene Regulation and its Pathways in Chinese Holstein Cows with Clinical Mastitis Caused by .中国荷斯坦奶牛临床型乳腺炎相关基因调控及其通路的初步研究 (原文结尾不完整,缺少具体病原体等内容)
J Vet Res. 2022 May 5;66(2):179-187. doi: 10.2478/jvetres-2022-0022. eCollection 2022 Jun.
3
Exploring Diagnostic Biomarkers and Comorbid Pathogenesis for Osteoarthritis and Metabolic Syndrome via Bioinformatics Approach.

本文引用的文献

1
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.在阿尔茨海默病小鼠模型中,纤维蛋白沉积会加速神经血管损伤和神经炎症。
J Exp Med. 2007 Aug 6;204(8):1999-2008. doi: 10.1084/jem.20070304. Epub 2007 Jul 30.
2
Expression and function of junctional adhesion molecule-C in human and experimental arthritis.人及实验性关节炎中连接黏附分子C的表达与功能
Arthritis Res Ther. 2007;9(4):R65. doi: 10.1186/ar2223.
3
Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells.
通过生物信息学方法探索骨关节炎和代谢综合征的诊断生物标志物及共病发病机制。
Int J Gen Med. 2021 Sep 29;14:6201-6213. doi: 10.2147/IJGM.S325561. eCollection 2021.
4
Antioxidant and Anti-Inflammatory Effects of and : In Silico, Biochemical and Histological Study.[具体物质名称1]和[具体物质名称2]的抗氧化和抗炎作用:计算机模拟、生化及组织学研究
Foods. 2021 Jun 15;10(6):1383. doi: 10.3390/foods10061383.
5
Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?使用 PAR4 抑制作为抗血栓形成的方法:为什么、如何以及何时?
Int J Mol Sci. 2019 Nov 11;20(22):5629. doi: 10.3390/ijms20225629.
6
Effects of Hydroalcoholic Extract on Inflammatory Mediators and Oxidative Stress Markers in Carrageenan-Induced Paw Oedema in Mice.水醇提取物对角叉菜胶诱导的小鼠足肿胀炎症介质和氧化应激标志物的影响。
Biomed Res Int. 2018 Jul 9;2018:3785487. doi: 10.1155/2018/3785487. eCollection 2018.
7
Proteinases and their receptors in inflammatory arthritis: an overview.炎症性关节炎中的蛋白酶及其受体:概述。
Nat Rev Rheumatol. 2018 Mar;14(3):170-180. doi: 10.1038/nrrheum.2018.17. Epub 2018 Feb 8.
8
Protease-activated receptor 4: from structure to function and back again.蛋白酶激活受体4:从结构到功能,再回归结构
Br J Pharmacol. 2016 Oct;173(20):2952-65. doi: 10.1111/bph.13455. Epub 2016 Mar 10.
9
Evolution of the protease-activated receptor family in vertebrates.脊椎动物中蛋白酶激活受体家族的进化
Int J Mol Med. 2016 Mar;37(3):593-602. doi: 10.3892/ijmm.2016.2464. Epub 2016 Jan 22.
10
Protease-activated receptor 4: a critical participator in inflammatory response.蛋白酶激活受体 4:炎症反应的关键参与者。
Inflammation. 2015 Apr;38(2):886-95. doi: 10.1007/s10753-014-9999-6.
纤维蛋白原和纤维蛋白可诱导分离的外周血单核细胞合成促炎细胞因子。
Thromb Haemost. 2007 May;97(5):822-9. doi: 10.1160/th07-01-0039.
4
Alternatively spliced tissue factor - one cut too many?可变剪接的组织因子——切割过度?
Thromb Haemost. 2007 Jan;97(1):5-8. doi: 10.1160/th06-11-0670.
5
Evaluation of protease-activated receptor 2 in murine models of arthritis.蛋白酶激活受体2在小鼠关节炎模型中的评估
Arthritis Rheum. 2007 Jan;56(1):101-7. doi: 10.1002/art.22312.
6
Identification and characterization of murine alternatively spliced tissue factor.小鼠可变剪接组织因子的鉴定与特性分析
J Thromb Haemost. 2006 Jan;4(1):158-67. doi: 10.1111/j.1538-7836.2005.01680.x.
7
Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes.可溶性组织因子是2型糖尿病患者微血管疾病进展的一个候选标志物。
J Thromb Haemost. 2006 Mar;4(3):574-80. doi: 10.1111/j.1538-7836.2005.01763.x. Epub 2005 Dec 22.
8
Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.促凝血可溶性组织因子在炎症细胞因子的作用下从内皮细胞中释放出来。
Circ Res. 2005 Jun 24;96(12):1233-9. doi: 10.1161/01.RES.0000171805.24799.fa. Epub 2005 May 26.
9
Reduction of arthritis severity in protease-activated receptor-deficient mice.蛋白酶激活受体缺陷小鼠关节炎严重程度降低。
Arthritis Rheum. 2005 Apr;52(4):1325-32. doi: 10.1002/art.21001.
10
Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.在一种用于多发性硬化症的肿瘤坏死因子转基因小鼠模型中,纤维蛋白消耗可减轻炎症并延缓脱髓鞘的发生。
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6698-703. doi: 10.1073/pnas.0303859101. Epub 2004 Apr 19.